CRP Invests in Gamma Medica-IDEAS, Inc. (GMI)

Capital Resource Partners, in partnership with Psilos Group, provided GMI with $17.5 million of growth and recapitalization financing to address working capital needs and to fund the market launch of the LumaGEM® Molecular Breast Imaging system.
GMI is a developer of advanced imaging systems that provide industry leading performance and resolution for both pre-clinical and clinical applications. The Company offers the world’s only fully-digital tri-modality (PET, SPECT and CT) pre-clinical imaging platform and has just launched the LumaGEM® Molecular Breast Imaging system that is able to identify millimeter sized lesions at a fraction of the cost of breast MRI – both in terms of procedure reimbursement and the cost of the device itself. The combination of improved diagnostic accuracy and overall cost reduction is able to effectively align incentives across payors, providers and patients – an underlying tenet of where healthcare is headed.

Nick Scola, a Partner at Capital Resource Partners will be joining the company’s board of directors.

Leave a Reply

Your email address will not be published. Required fields are marked *